How Much Does Testosterone Enanthate Cost in Washington in 2026?

Retail Cash Prices Across Washington Pharmacies

The average cash price for a one-month supply of testosterone enanthate at Washington retail pharmacies sits near $70 in 2026, while the manufacturer list price hovers around $120 per month. That gap matters. Patients paying out of pocket can save substantially by comparing pharmacy-level pricing across the state, because markups vary widely between chains and independents.

Testosterone enanthate is dispensed as an intramuscular injection, typically in 200 mg/mL vials of 1 mL or 5 mL. A common replacement dose for male hypogonadism falls between 100 mg and 200 mg every seven days, a range supported by the Endocrine Society's 2018 Clinical Practice Guideline, which recommends titrating to mid-normal serum testosterone levels of 450 to 600 ng/dL [1]. The 5 mL vial is more cost-effective per milligram. A single 5 mL vial at $70 to $90 can cover four to five weeks of therapy at 200 mg weekly, bringing the per-injection cost below $20.

Pharmacy pricing tools such as GoodRx and RxSaver show Washington-specific quotes that fluctuate by zip code. Costco pharmacies in the Seattle metro area and Spokane often post lower cash prices than CVS or Walgreens for generic testosterone enanthate. The FDA-approved prescribing information for testosterone enanthate lists the standard intramuscular formulation, and all generic versions are AB-rated as therapeutically equivalent [2].

Washington Medicaid Coverage and Prior Authorization

Washington Apple Health (Medicaid) covers testosterone enanthate for diagnosed male hypogonadism, but requires prior authorization before dispensing. This means patients and prescribers must document clinical necessity with lab-confirmed low testosterone (typically two morning total testosterone levels below 300 ng/dL) along with signs or symptoms of androgen deficiency.

The PA process usually takes three to five business days. The Endocrine Society guideline defines the diagnostic threshold as total testosterone below 300 ng/dL measured on at least two separate mornings, collected before 10 a.m. [1]. Washington Medicaid aligns with this criterion. Once approved, the PA remains valid for 12 months before renewal.

Copays under Medicaid are minimal. Most enrollees pay $0 to $3 per prescription fill. The Washington Health Care Authority's preferred drug list includes generic testosterone enanthate as a covered androgen, making it one of the most affordable testosterone replacement options for Medicaid-eligible residents [3]. Patients denied PA can appeal through the Health Care Authority's fair hearing process, and approval rates on appeal exceed 60% when documentation includes both confirmatory lab values and documented symptoms such as fatigue, decreased libido, or loss of lean mass.

Commercial Insurance Coverage in Washington

Most major commercial insurers operating in Washington (Premera Blue Cross, Regence, Kaiser Permanente, Molina, and Coordinated Care) list generic testosterone enanthate on their formularies. Copays generally fall between $10 and $45 per month depending on the plan tier and whether the pharmacy is in-network.

Plans that classify testosterone enanthate as a Tier 1 or Tier 2 generic typically charge $10 to $25 per fill. High-deductible health plans may require patients to pay the full negotiated rate until the deductible is met, which can range from $50 to $90 per fill. The landmark Testosterone Trials (TTrials) published in the New England Journal of Medicine demonstrated that testosterone replacement improved sexual function, physical activity, and mood in men 65 and older with confirmed low testosterone, strengthening the evidence base that insurers use to justify formulary inclusion [4].

Dr. Bradley Anawalt, an endocrinologist at the University of Washington, has stated: "For the vast majority of men with well-documented hypogonadism, insurers should not be creating barriers to a generic injectable that costs less than many monthly vitamins" [5]. This perspective reflects a broader trend. Washington's Office of the Insurance Commissioner has received fewer testosterone-related coverage complaints year over year since 2023, suggesting that formulary access is improving across the state.

Step therapy requirements are uncommon for testosterone enanthate specifically, because it is already the first-line injectable option. Some plans do require trial of testosterone enanthate before approving more expensive formulations like testosterone undecanoate (Aveed) or nasal testosterone (Natesto).

Compounded Testosterone Enanthate in Washington

Compounded testosterone enanthate is legal in Washington through licensed 503A compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and must comply with USP Chapter 797 standards for sterile preparations.

The average monthly cost for compounded testosterone enanthate from a Washington 503A pharmacy is approximately $80. That price is slightly higher than the retail generic average because compounding pharmacies often include customized concentrations (e.g., 250 mg/mL instead of the standard 200 mg/mL) or combination formulations with other compounds.

Why would a patient choose compounded over commercial? Three common reasons. First, patients who need non-standard concentrations or volumes. Second, patients allergic to specific inactive ingredients (such as sesame oil or chlorobutanol) in the FDA-approved product. Third, patients who prefer subcutaneous injection with a thinner-gauge needle, using a concentration optimized for smaller injection volumes.

Washington state does not restrict 503A compounding pharmacies from preparing testosterone enanthate as long as a valid patient-specific prescription exists. The pharmacy must hold an active Washington State Pharmacy License and meet all Board of Pharmacy compounding regulations. The FDA's guidance on 503A compounding outlines federal requirements that apply alongside state rules [6]. Patients should verify that any compounding pharmacy they use holds current accreditation from the Pharmacy Compounding Accreditation Board (PCAB) or an equivalent body.

Telehealth Access for Testosterone Enanthate in Washington

Washington permits telehealth prescribing of testosterone enanthate. Prescribers can evaluate patients via synchronous video visits, order lab work electronically, and transmit prescriptions to any licensed pharmacy in the state.

Washington's telehealth parity law (RCW 48.43.735) requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits, removing a financial barrier for patients who live in rural counties east of the Cascades where endocrinologists are scarce. The American Urological Association's 2018 guideline on testosterone deficiency supports remote follow-up for stable TRT patients, recommending monitoring of hematocrit, PSA, and testosterone levels at 3 to 6 month intervals after dose stabilization [7].

Telehealth TRT platforms operating in Washington typically charge between $99 and $199 for the initial consultation, with follow-ups ranging from $50 to $99. Some bundle lab work and medication into a monthly subscription of $150 to $250. For patients with insurance, the telehealth visit itself is usually covered, and the prescription can be filled at a local pharmacy at the standard copay, which is often cheaper than bundled subscription pricing.

One consideration: Washington law requires that the prescriber hold an active Washington state medical license or be authorized through an interstate compact. The prescriber-patient relationship must be established via a real-time audio-video encounter for the initial prescription. Subsequent refills and dose adjustments can occur via asynchronous communication.

Discount Programs and Savings Strategies

Several pathways exist for reducing testosterone enanthate costs in Washington beyond standard insurance. Manufacturer savings cards, pharmacy discount programs, and patient assistance programs can bring monthly costs below $50 for eligible patients.

GoodRx, SingleCare, and RxSaver coupons frequently reduce the retail cash price to $30 to $50 for a 1 mL vial of testosterone enanthate 200 mg/mL at major Washington pharmacies. These coupons work at checkout and do not require insurance. They cannot be combined with insurance copays or used by patients enrolled in federal healthcare programs like Medicaid or Medicare Part D.

The American Association of Clinical Endocrinology (AACE) 2020 position statement on male hypogonadism emphasized that cost should not prevent access to testosterone replacement in appropriately diagnosed patients: "Barriers to affordable androgen therapy undermine adherence and long-term outcomes in men with confirmed hypogonadism" [8]. This guidance reinforces why Washington providers routinely help patients identify the lowest-cost dispensing option.

Mark Cuban Cost Plus Drugs (costplusdrugs.com) ships to Washington addresses and prices generic testosterone enanthate (5 mL, 200 mg/mL) at a transparent markup over manufacturing cost plus a flat pharmacy fee. As of early 2026, their price has been competitive with the lowest GoodRx-quoted prices in the state.

For uninsured patients, community health centers in Washington (FQHCs) often purchase testosterone enanthate through the 340B Drug Pricing Program, which can result in patient costs as low as $15 to $30 per month on a sliding fee scale. Washington has more than 30 FQHCs across the state, concentrated in King, Pierce, Snohomish, and Yakima counties.

Dosing, Administration, and Monitoring Costs

The cost equation for testosterone enanthate extends beyond the medication itself. Lab monitoring, syringes, and follow-up visits contribute to the total annual expense of TRT in Washington.

Standard monitoring includes total testosterone, free testosterone, hematocrit, PSA (for men over 40), and a lipid panel. The Endocrine Society guideline recommends measuring testosterone and hematocrit at 3 months, 6 months, and then annually once stable [1]. A basic TRT monitoring panel at a Washington commercial lab (Quest or Labcorp) costs $80 to $150 without insurance, or $0 to $30 with most commercial plans.

Injection supplies add a small recurring cost. A box of 100 intramuscular needles (22-gauge, 1-inch) and syringes runs approximately $15 to $25 and lasts most patients 20 to 25 weeks at weekly dosing. Alcohol prep pads and sharps containers add another $5 to $10 per quarter.

Tallying all components, a Washington patient on generic testosterone enanthate with commercial insurance can expect to spend roughly $300 to $600 per year out of pocket for the medication, labs, supplies, and copays. An uninsured cash-pay patient using discount coupons and direct-pay labs might spend $700 to $1,200 annually. These figures assume a stable dose with no complications.

Hematocrit monitoring deserves special attention. The TTrials data showed that testosterone treatment increased hematocrit levels, with 3.5% of treated men exceeding 54% versus 0.3% on placebo [4]. Washington providers typically set a hematocrit threshold of 54% as the trigger for dose reduction or therapeutic phlebotomy. Therapeutic phlebotomy at a Washington blood center or clinic costs $50 to $150 per session without insurance.

How Washington Compares to Neighboring States

Washington's average testosterone enanthate pricing is competitive within the Pacific Northwest. Oregon's retail cash average is similar at approximately $65 to $75 per month, while Idaho tends to run $5 to $10 higher due to fewer pharmacy competitors in rural areas. California's prices are comparable to Washington in urban areas but can spike in remote Northern California counties.

Washington's Medicaid coverage with PA mirrors Oregon's approach but differs from Idaho, where Medicaid coverage for testosterone requires more restrictive documentation including bone density or anemia data in addition to low testosterone levels. Washington's telehealth framework is among the most permissive in the region, with Idaho only recently expanding telehealth prescribing for controlled substances in 2025.

The CDC's National Health and Nutrition Examination Survey (NHANES) data indicate that roughly 2% of men aged 40 to 79 use some form of testosterone therapy nationally, a figure that has increased threefold since 2010 [9]. Washington's per-capita TRT utilization tracks slightly above the national average, likely reflecting the state's strong telehealth infrastructure and relatively broad insurance coverage.